CP-532903 is a selective adenosine A3 subtype receptor agonist. It has antiinflammatory effects and has been shown to reduce superoxide generation in damaged tissues and protects against tissue damage following myocardial ischemia mediated via an interaction with ATP-sensitive potassium channels.
This page contains content from the copyrighted Wikipedia article "CP-532903"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
